Trials / Completed
CompletedNCT02517580
Vitamin K2 Supplementation and Arterial Stiffness in the Renal Transplant Population (The KING Trial)
Vitamin K2 Supplementation and Effect on Arterial Stiffness Progression in the Renal Transplant Population
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Lebanese American University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single arm, single center clinical trial that aims to evaluate the effect of 8 weeks of vitamin K2 replacement (360 mcg/day) on the progression of arterial stiffness in stable renal transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin K2 (MK7) |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-08-07
- Last updated
- 2018-02-09
- Results posted
- 2018-02-09
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT02517580. Inclusion in this directory is not an endorsement.